๐ŸงฌTidera Health

Tidera provides educational trial discovery tools and does not provide medical advice or determine eligibility. Always discuss options with your care team.

Condition Guides9 min readICD-10: M05

Rheumatoid Arthritis Clinical Trials: Biologics, JAK Inhibitors, and New Targets

By Tidera Health Editorial Teamยท

RA trial eligibility often depends on methotrexate or anti-TNF failure. Here's what's recruiting in 2025 and who can enroll.

About this article: Educational and informational only. Does not constitute medical advice or eligibility guidance. Always discuss clinical trial options with your care team. Verify current trial status at ClinicalTrials.gov.

What You Need to Know

What RA clinical trials are recruiting in 2025 โ€” new biologics, next-generation JAK inhibitors, bispecific antibodies, and tapering studies for patients in remission.

Find recruiting trials for your condition

Search ClinicalTrials.gov in real time โ€” matched to your profile, explained in plain English. Free, no account required.

Start Free Search โ†’

Explore Trials for This Condition

For condition-specific trial information, including common eligibility requirements, trial types, and direct search links, visit the Tidera condition page:

How Tidera Health Can Help

Tidera Health searches ClinicalTrials.gov in real time and uses AI to explain which trials may be relevant to your condition, age, location, and treatment history. It's free, requires no account, and stores no health data.

Enter your condition and location to see currently recruiting trials matched to your profile โ€” with plain-English eligibility explanations and questions to ask the research coordinator.

Topics

rheumatoid arthritis clinical trialsRA biologic trialJAK inhibitor RA trialMTX-IR clinical trial

Related Condition Page

Find recruiting trials, eligibility information, and FAQs for this condition.

View condition trial guide โ†’

Find recruiting trials for your condition

Enter your condition, age, and location. We search ClinicalTrials.gov in real time and explain each trial in plain English. Free, no account required.